|
WO2013150354A1
|
|
Local composition to treat stress urinary incontinence in a female subject
|
|
US2015011640A1
|
|
Gynecologic composition to treat vulvar vestibulitis
|
|
WO2012017288A2
|
|
Supramolecular complexes of polyanionic polymers and spermidine in tissue maintenance and repair
|
|
WO2012017290A1
|
|
Inclusion complexes of cyclodextrins with spermidine, and proliferative/reparative compositions comprising thereof
|
|
WO2011158089A1
|
|
N-containing polymers in topical compositions to suppress metal induced allergic reactions
|
|
WO2011067653A1
|
|
Oral compositions for use in the mercury intoxication from dental amalgam
|
|
WO2010092468A1
|
|
Composition comprising alginates and d-limonene to treat gerd and dyspepsia
|
|
WO2010092467A1
|
|
Medicament comprising terpenoid cholinesterase inhibitor for treatment of dismotility disorder
|
|
WO2010143006A1
|
|
Orally bioavailable iron chelators in the treatment of an inflammatory bowel disease
|
|
WO2010136839A1
|
|
Use of deferoxamine and related compounds in targeted delivery forms to treat an inflammatory bowel disease
|
|
WO2010133906A2
|
|
Use of specific chelating polymers in medicaments for the treatment of inflammatory bowel disease
|
|
WO2010133907A1
|
|
Hexadentate chelators in inflammatory bowel disease
|
|
WO2010109257A1
|
|
Composition to treat protein intolerance
|
|
WO2010109256A1
|
|
Enhanced treatment of joint and connective tissue damage
|
|
WO2010092415A1
|
|
Combination of hesperidin and antacids in the treatment of gastro-esophageal reflux disease (gerd)
|
|
WO2008090440A1
|
|
Lipid-based gynaecologic suppository
|
|
WO2008072072A1
|
|
Terminally unsaturated vanilloids and medicinal application thereof
|
|
WO2008065527A2
|
|
Gallic acid esters of fragrant alcohols
|
|
WO2008035152A1
|
|
Cosmetic method to remove the dark undereye marks
|
|
WO2008044099A1
|
|
Charge transfer complexes in the treatment of inflammatory bowel diseases
|
